Navigation Links
Inovio Pharmaceuticals to Host Second Quarter 2014 Financial Results Call on August 11, 2014
Date:8/1/2014

rsity of Manitoba. For more information, visit www.inovio.com.

This press release contains certain forward-looking statements relating to our business, including our plans to develop electroporation-based drug and gene delivery technologies and DNA vaccines and our capital resources. Actual events or results may differ from the expectations set forth herein as a result of a number of factors, including uncertainties inherent in pre-clinical studies, clinical trials and product development programs (including, but not limited to, the fact that pre-clinical and clinical results referenced in this release may not be indicative of results achievable in other trials or for other indications, that the studies or trials may not be successful or achieve the results desired, including safety and efficacy for VGX-3100, that pre-clinical studies and clinical trials may not commence or be completed in the time periods anticipated, that results from one study may not necessarily be reflected or supported by the results of other similar studies and that results from an animal study may not be indicative of results achievable in human studies), the availability of funding to support continuing research and studies in an effort to prove safety and efficacy of electroporation technology as a delivery mechanism or develop viable DNA vaccines, our ability to support our broad pipeline of SynCon® active immune therapy and vaccine products, the adequacy of our capital resources, the availability or potential availability of alternative therapies or treatments for the conditions targeted by the company or its collaborators, including alternatives that may be more efficacious or cost-effective than any therapy or treatment that the company and its collaborators hope to develop, evaluation of potential opportunities, issues involving product liability, issues involving patents and whether they or licenses to them will pro
'/>"/>

SOURCE Inovio Pharmaceuticals, Inc.
Copyright©2014 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. Inovio Pharmaceuticals HPV Immunotherapy Achieves Primary Efficacy Endpoint in Randomized Phase II Cervical Dysplasia Trial
2. Inovio Pharmaceuticals to Present at Biotech Showcase 2014 Investor Conference
3. CEO Dr. Joseph Kim to Discuss Inovios Innovative Approach to Treating Cervical Cancer in an Expert Panel
4. Inovio Pharmaceuticals Reports 2013 Third Quarter Financial Results
5. Inovio Pharmaceuticals Therapeutic Vaccine for Hepatitis C Enters Phase I Clinical Trial
6. Inovio Pharmaceuticals to Participate in Immunotherapy Panel and Present at the 12th Annual BIO Investor Forum
7. Inovio Pharmaceuticals Targets Transformation of Monoclonal Antibody Therapies
8. Inovio Pharmaceuticals to Present at Investor Conferences and Town Hall Los Angeles
9. Roche and Inovio Pharmaceuticals partner on Inovios prostate cancer and hepatitis B immunotherapy products
10. Inovio Pharmaceuticals to Present at Upcoming Investor Conferences
11. Inovio Pharmaceuticals Malaria DNA Vaccine Demonstrates Robust Immune Responses in Animal Models
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/22/2015)... May 22, 2015 /CNW/ - More than fifty years ago, ... morning sickness in expectant mothers. Tragically, Thalidomide caused serious and ... Support has been provided to survivors over ... Canada in 1991 and settlements from ... a legal obligation to provide support, we have a clear ...
(Date:5/22/2015)... , May 22, 2015 Electrophysiologist ... Institute recently traveled to Boston, MA ... at the 2015 Heart Rhythm Society conference. These ... to focus on the ideas, people and technology ... Convergent is a hybrid, minimally invasive cardiac operation ...
(Date:5/22/2015)... NEW YORK , May 22, 2015 /PRNewswire/ ... approval of Zarxio (filgrastim-sndz) -- the first biosimilar ... -- points toward growth in the ... Information. The mainstream CMO industry is geared to ... infrastructure to produce major biopharmaceutical products. The healthcare ...
Breaking Medicine Technology:Statement from Minister Ambrose on Thalidomide 2Statement from Minister Ambrose on Thalidomide 3St. Joseph's Hospital Heart Institute Physician Presents at Heart Rhythm Society 2St. Joseph's Hospital Heart Institute Physician Presents at Heart Rhythm Society 3Kalorama: First FDA-Approved Biosimilar Brings Hope for CMO Growth 2Kalorama: First FDA-Approved Biosimilar Brings Hope for CMO Growth 3Kalorama: First FDA-Approved Biosimilar Brings Hope for CMO Growth 4
... 1, 2012  PDI, Inc. (Nasdaq: PDII ) ... and full year 2011 financial results on Wednesday, March ... conference call on Thursday, March 8, at 8:30 am ... March 8, 2012Time:8:30 am Eastern timeDial-in numbers:(866) 644-4654 (U.S. ...
... therapies for foot wounds are saving limbs, restoring mobility, ... who suffer from non-healing foot ulcers. "For ... wounds can be a tremendous problem, making these advanced ... clinical professor of surgery at Yale School of Medicine. ...
Cached Medicine Technology:Advanced Treatments Help Hard-to-Heal Diabetic Foot Ulcers—and Improve Lives 2Advanced Treatments Help Hard-to-Heal Diabetic Foot Ulcers—and Improve Lives 3
(Date:5/23/2015)... Injury lawyer Steven H. Heisler commented today on the ... legislature but which has not been signed to date by ... 449 with overwhelming bipartisan support on April 10, 2015, ... This bill ensures that fracking is prohibited in Maryland through ... of fracking to our water supplies and the air we ...
(Date:5/22/2015)... 22, 2015 The American College of ... in June. They will hold a webinar on the ... two-day class on Classical Chinese Medicine. , Webinar – ... Steve Given, the Dean of Clinical Education, will lead ... First Professional Doctorate program. ACTCM is currently developing this ...
(Date:5/22/2015)... May 22, 2015 Hundreds of ... behalf of individuals who allegedly experienced serious internal ... continue to move forward in the U.S. District ... Pretrial Order dated May 4, 2015, the Court ... and electronically stored information. Among other things, the ...
(Date:5/22/2015)... Combination therapy, or polytherapy, will likely ... pulmonary disorder (COPD) as the dominant companies like ... well as Germany’s Boehringer Ingelheim compete with each ... market payers, clinicians and patients be disposed to ... new ones? , In spite of recently approved ...
(Date:5/22/2015)... Family, friends, students, colleagues, mentors and fellow physicians ... D. Leffall, on Monday, May 18, with an 85th ... in the hospital’s Tower Auditorium. Leffall’s younger sister, 83-year-old ... to keep the secret. “I’d like to go in ... know something is up,” she said. , After more ...
Breaking Medicine News(10 mins):Health News:Baltimore Attorney Urges Governor Hogan to Sign the Fracking Moratorium Bill 2Health News:Baltimore Attorney Urges Governor Hogan to Sign the Fracking Moratorium Bill 3Health News:ACTCM Announces Upcoming June Events 2Health News:Court Overseeing Federal Xarelto Lawsuits Establishes Procedures Governing Preservation of Documents, Electronically Stored Information 2Health News:Court Overseeing Federal Xarelto Lawsuits Establishes Procedures Governing Preservation of Documents, Electronically Stored Information 3Health News:Court Overseeing Federal Xarelto Lawsuits Establishes Procedures Governing Preservation of Documents, Electronically Stored Information 4Health News:Chronic Obstructive Pulmonary Disorder Therapeutics Market Discussed in In-demand FirstWord Report Published at MarketPublishers.com 2Health News:Colleagues Surprise Dr. LaSalle Leffall with 85th Birthday Celebration 2
... Other Providers Would Likely Demand Similar,Treatment Next Year, ... released a new ad today warning policymakers,that other Medicare ... the "same prompt-pay deal" next year if Congress requires,pharmacists ... "Paying one group of Medicare providers twice as ...
... Older people are especially,at risk from heat-related health problems such ... currently experiencing, now is not,the time to do chores, run ... for all ages, but potentially life threatening,for older persons," according ... 10 tips for dealing with a heat wave:, 1. ...
... The 125,000-member American College of Physicians (ACP) today ... the Medicare Improvements for Patients and Providers Act of ... S. 3101 because it addresses and incorporates three of ... MD, FACP, wrote Senator Max Baucus (D-MT), chairman of ...
... June 9 Mylan Inc. (NYSE: MYL ),today ... from the U.S. Food and Drug Administration (FDA) for ... mg and 10,mg., Zaleplon Capsules are the generic ... of approximately $88 million for,the 12 months ending March ...
... donates $100,000 to American Red Cross, INDIANAPOLIS, June ... of Eli Lilly and Company (NYSE: LLY ), ... to aid,Indiana tornado and flood victims. More than 44 ... Mitch Daniels as a result of deadly,tornadoes and severe ...
... MADISON, N.J., June 9 Wyeth (NYSE: ... the Goldman Sachs Twenty-Ninth,Annual Global Healthcare Conference on ... for Wyeth will be Bernard Poussot, President and ... webcast live for investors at, http://www.wyeth.com and ...
Cached Medicine News:Health News:New PCMA Ad: Pharmacist 'Prompt Pay' Will Trigger 'Domino Effect' Among Other Medicare Providers 2Health News:How Seniors Can Beat the Heat 2Health News:ACP pledges support for Medicare improvements for Patients and Providers Act of 2008 2Health News:Lilly to Provide Aid to Indiana Tornado and Flood Victims 2
... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
Medicine Products: